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Abstract
Background—Four subtypes of bipolar disorder (BP) – bipolar I, bipolar II, cyclothymia and
bipolar not otherwise specified (NOS) – are defined in DSM-IV-TR. Though the diagnostic
criteria for each subtype are intended for both adults and children, research investigators and
clinicians often stray from the DSM when diagnosing pediatric bipolar disorder (PBD)
(Youngstrom, 2009), resulting in a lack of agreement and understanding regarding the PBD
subtypes.
Methods—The present study uses the diagnostic validation method first proposed by Robins and
Guze (1970) to systematically evaluate cyclothymic disorder as a distinct diagnostic subtype of
BP. Using a youth (ages 5–17) outpatient clinical sample (n=827), participants with cyclothymic
disorder (n=52) were compared to participants with other BP spectrum disorders and to
participants with non-bipolar disorders.
Results—Results indicate that cyclothymic disorder shares many characteristics with other
bipolar subtypes, supporting its inclusion on the bipolar spectrum. Additionally, cyclothymia
could be reliably differentiated from non-mood disorders based on irritability, sleep disturbance,
age of symptom onset, comorbid diagnoses, and family history.
Limitations—There is little supporting research on cyclothymia in young people; these analyses
may be considered exploratory. Gaps in this and other studies are highlighted as areas in need of
additional research.
Conclusions—Cyclothymic disorder has serious implications for those affected. Though it is
rarely diagnosed currently, it can be reliably differentiated from other disorders in young people.
Failing to accurately diagnose cyclothymia, and other subthreshold forms of bipolar disorder,
contributes to a significant delay in appropriate treatment and may have serious prognostic
implications.
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Pediatric bipolar disorder (PBD) is a relatively new concept within psychology and has been
the source of diagnostic debate. Although there is generally agreement regarding the
phenotypes for bipolar I and II, the definitions of bipolar disorder not otherwise specified
(BP NOS) and cyclothymic disorder are still subject to controversy (Youngstrom, 2009). In
fact, although there are distinct DSM criteria for each, it has been noted in the literature that
many research groups do not attempt to differentiate subthreshold subtypes, relying instead
on a less-precisely defined “NOS” grouping (Kessler, Avenevoli, & Merikangas, 2001;
Youngstrom, Birmaher, & Findling, 2008). The differentiation of subthreshold bipolar
disorder subtypes is important in order to elucidate the risk factors, developmental course,
and potential for preventative measures that apply to each.
Subthreshold cases of PBD may, in fact, be in greatest need of investigation. These
presentations are more common than BP I and II in young people (Lewinsohn, Klein, &
Seeley, 1995; Merikangas et al., 2007; Van Meter, Moreira, & Youngstrom, 2010) and
adults (Akiskal, Lancrenon, & Hantouche, 2006; Hantouche, 2009) and prove to be just as
impairing as the syndromal subtypes in both clinical and community studies (Axelson et al.,
2006; Birmaher et al., 2009; Birmaher et al., 2006; Findling et al., 2005; Judd & Akiskal,
2003; Kessler et al., 2001). Furthermore, subthreshold bipolar disorder likely offers the best
opportunity for preventative intervention (Berk et al., 2007; Chang, 2008; Klein, Depue, &
Slater, 1986; Miklowitz & Chang, 2008).
For the most part, cyclothymia is not described in research settings or diagnosed clinically
(Youngstrom, Youngstrom, & Starr, 2005). The absence of cyclothymia in research studies
and clinical settings suggests that cases of cyclothymic disorder are either being (1)
misdiagnosed as another mood disorder, particularly BP NOS, (2) misdiagnosed as a non-
affective disorder, or (3) not coming to scientific or clinical attention. Failure to recognize
subthreshold cases may leave up to one-third of people with bipolar disorder untreated
(Angst, Merikangas, & Preisig, 1997). This is a real concern considering that early onset
bipolar disorder may represent a more pernicious type than adult onset, and early treatment
could stave off some consequences associated with the disorder (Berk et al., 2007; Perlis et
al., 2004).
The validity of pediatric bipolar subtypes may be of particular interest now, as DSM-5 and
WHO/ICD-11 committees are meeting to determine the future classification system. In order
to examine the validity of cyclothymic disorder in youth, a review of the pediatric bipolar
disorder literature and previous studies of cyclothymia in adults was conducted. Seven
constructs, Depression and Hypomania, Irritability, Comorbidity, Age of Onset, Sleep
Disturbance, and Family History, were identified to explore as potential discriminating
clinical features of pediatric cyclothymia (Akiskal, Djenderedjian, Rosenthal, & Khani,
1977; Birmaher et al., 2009; Birmaher et al., 2006; Depue et al., 1981; Findling et al., 2005;
Howland & Thase, 1993; Klein et al., 1986)
In order to be diagnosed with cyclothymic disorder, according to DSM nosology, youth
must suffer impairing symptoms, both depressive and hypomanic, that fail to meet full
criteria for either number of symptoms or duration for mania or major depression.
Additionally, both depressive and hypomanic symptoms must have been present for at least
10 out of 12 months to meet criteria. In addition to chronic mood disruption, irritability
during both hypomanic and depressive periods has been described as a marker of
cyclothymic disorder (Akiskal et al., 1977). Unfortunately, irritability is also a symptom of
many other childhood disorders, resulting in frequent misdiagnosis (Biederman et al., 2000;
Youngstrom et al., 2008). In the case of cyclothymia, the irritability should coincide with
episodes of hypomanic and depressive symptoms – not occur persistently as it might in other
disorders. Concentrating on the episodic nature of the disorder is the best way to ensure that
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a symptom is due to the bipolar disorder (Youngstrom et al., 2008). In the present study, we
hypothesized that youth with cyclothymia would report elevated irritability corresponding
with both elevated and depressed mood, reflecting significant disturbance during both mood
phases.
The presence of other psychiatric disorders is common in youth with bipolar disorder, often
making diagnosis difficult and complicating treatment (Lewinsohn et al., 1995; Spencer et
al., 2001; Wozniak et al., 1995). Two of the most common comorbid diagnoses are ADHD
and anxiety disorders (Kowatch, Youngstrom, Danielyan, & Findling, 2005). Given its
common symptoms, particularly restlessness, irritability and impulsivity, cyclothymia is
often misdiagnosed and it may be several years before a proper diagnosis is made (Faedda,
Baldessarini, Glovinsky, & Austin, 2004). Some experts hypothesize that a prolonged period
to diagnosis may result in greater burden of illness, including more comorbid diagnoses
(McElroy, Strakowski, West, Keck, & McConville, 1997; Schraufnagel, Brumback, Harper,
& Weinberg, 2001). Additionally, cyclothymia is associated with a broad range of familial
psychiatric disorders, which may lead to increased comorbidity (Akiskal, Hantouche, &
Allilaire, 2003; Findling et al., 2005). We hypothesized that youth with cyclothymia would
be diagnosed with more comorbid diagnoses than the other youth in the study, and that they
would most often report comorbid ADHD or anxiety.
The age of symptom onset in bipolar disorder has important implications for prognosis
(Craney & Geller, 2003). Generally, the earlier symptoms begin, the more severe the disease
will ultimately become (Perlis et al., 2004). Considering (1) that cyclothymia may have its
foundation in temperament, (2) that cyclothymia can be the prodrome to other forms of
bipolar disorder (Akiskal et al., 1985), and (3) that subsyndromal bipolar may have a
younger mean age of symptom onset than BP I and II (Lewinsohn, Klein, & Seeley, 2000),
we hypothesized that cyclothymia would have an earlier age of onset than other forms of
bipolar disorder (Dickstein et al., 2005). Additionally, research suggests that the first mood
episode is more often depressive than elevated (Strober et al., 1995); therefore we expected
the index episode of cyclothymia to be characterized by depressive symptoms.
A reliable way to identify youth with bipolar disorder is by assessing sleep disturbance
coinciding with mood episodes (Geller et al., 2002; Harvey, Mullin, & Hinshaw, 2006).
People with cyclothymic disorder often experience significant sleep disturbance, during both
hypomanic and depressive episodes, in part due to the restlessness and agitation associated
with their disorder (Findling et al., 2005; Kowatch et al., 2005). In the present study, we
expected youth with cyclothymic disorder to report disordered sleep similar to that
experienced by the other youth with bipolar disorder, albeit less severe than those who
reported a history of a full manic episode.
There is significant evidence that bipolar disorder is heritable: A child of a parent with
bipolar disorder will be approximately 5 times more likely to develop bipolar than a child of
healthy parents (Hodgins, Faucher, Zarac, & Ellenbogen, 2002; Tsuchiya, Byrne, &
Mortensen, 2003). In a study of youth with manic symptoms, the youths with cyclothymic
disorder were more likely to have a parent with a bipolar disorder than any other diagnostic
group of youths (Findling et al., 2005). Additionally, there is evidence that the presence of a
family history of mood disorder is the key factor in differentiating people with cyclothymia
from others with subthreshold bipolar symptomatology (Akiskal et al., 1977; Depue, 1981).
In the present study, we hypothesized that youth with cyclothymia would report a family
history of bipolar disorder similar to other youth with bipolar disorders. In addition, we
expected youth with cyclothymia to report family history of other psychiatric disorders at a
higher rate than other diagnostic group of youths in the sample.
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The primary aim of this study is to explore the validity of cyclothymic disorder as a
diagnostic subtype of pediatric bipolar disorder. The Robins and Guze approach to
diagnostic validation has been used widely in research (Andreasen, 1995; Feighner et al.,
1972). It provides a framework of five categories (described as “phases”) of evidence
collection that promote a rigorous system for the categorization of disorders without being
prohibitively rigid (Widiger & Trull, 1991). In previous studies, cyclothymia in adults has
been validated using modified versions of the Robins and Guze phases (Akiskal et al., 1977;
Klein et al., 1986). Additionally, the Robins and Guze approaches have been used to
validate pediatric bipolar disorder, demonstrating the fit of this framework to this class of
disorders (Biederman et al., 2003; Findling et al., 2001; Geller & Tillman, 2005). Three of
the five validity criteria – Clinical Description, Delimitation from Other Disorders, and
Family Studies – will be addressed by data in this paper.
Methods
Participants
Participants were recruited from an urban community mental health center (N=647) and
from an academic outpatient medical center (N=180). A consecutive case series of patients
presenting for services at the community mental health clinic were invited to participate in
the study. The only eligibility requirements were that the patient was between the ages of
five and 18 years and that both the patient and their caregiver were able to speak English.
The participants from the academic outpatient medical center were recruited for various
treatment studies for bipolar disorder and other childhood disorders. Additionally, children
of parents with bipolar disorder were recruited to the academic center. The exclusionary
criteria at the academic center included the same age and language requirements as the
outpatient clinic; additionally, participants were excluded if they suffered from a pervasive
developmental disorder, or mental retardation.
Measures
Schedule for Affective Disorders and Schizophrenia for School-Age Children-
Present and Lifetime (K-SADS-PL) with Longitudinal Evaluation of All
Available Data (LEAD) diagnosis—(Used to measure: Diagnosis, Comorbidity, Age of
Onset). Diagnoses were made taking into account the information provided during the semi-
structured interview using the K-SADS-PL (Kaufman et al., 1997). All participants and their
families completed a K-SADS-PL, modified with the mood disorders module of the WASH-
U-K-SADS (Geller, Zimmerman, & Williams, 2001). The WASH-U-K-SADS inquires
about symptoms related to depression and mania that are not well-queried in other
diagnostic interviews. In order to achieve interrater reliability, research assistants were
required to shadow an experienced rater for at least five K-SADS and demonstrate item-
level kappa>.85. For this study, the Longitudinal Evaluation of All Available Data (LEAD)
standard of diagnosis was used to designate the youth with cyclothymic disorder, in addition
to all other diagnostic categories (Spitzer, 1983). The LEAD diagnoses take into account the
information collected through the K-SADS interview, study questionnaires, family history,
and clinical judgment. Kappa was 0.95 for bipolar diagnoses and 0.91 for all diagnoses
when comparing consensus to the K-SADS diagnosis (Youngstrom, Meyers, et al., 2005). In
order for a participant to receive a diagnosis of cyclothymic disorder, s/he would have to
meet criteria for hypomanic symptoms and depressive symptoms, along with the duration
criteria of being symptomatic (to the point of clinical impairment) for at least one year. The
other diagnostic categories used in this study were bipolar I, bipolar II, bipolar NOS,
depression (comprised of major depression, dysthymia, and depression NOS), ADHD, and
disruptive behavior disorders (DBD; comprised of ODD, CD, and DBD NOS).
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As operationalized in other research studies, age of onset refers to the age at which a
participant first met diagnostic criteria for a depressive, manic, hypomanic, or mixed episode
(Goldstein et al., 2005). Given the significant delay that often occurs before an accurate
bipolar diagnosis is made (Marchand, Wirth, & Simon, 2006), in this study, age of symptom
onset will be assessed by determining the youngest age of symptomatology, rather than
diagnosis, as reported in the K-SADS interview.
Parent General Behavior Inventory—(Used to measure: Irritability, Sleep
Disturbance). Irritability was assessed during periods of both depressive and elevated mood
using select items from the Parent-General Behavior Inventory (P-GBI)(Youngstrom,
Findling, Danielson, & Calabrese, 2001). The P-GBI is a modified version of the General
Behavior Inventory (GBI) (Depue, 1981), completed by parents about their child. The
questions comprise two scales, the depressive and the hypomanic/biphasic, both scales with
high construct validity and very high internal consistency (alphas of 0.97 for depression and
0.94 for hypomanic/biphasic) (Youngstrom et al., 2001). This scale was originally
developed in order to be sensitive to subthreshold manifestations of mood disorder and has
proven to do a good job discriminating cases from the full spectrum of bipolar disorders
(Depue, 1981; Youngstrom et al., 2004; Youngstrom, Meyers, et al., 2005).
Items representing depressive or hypomanic irritability were selected by three independent
raters. Reliability was high; for depressive irritability, items 3, 14, 34, 39, 44, 50, and 53
(Cronbach’s α .87) and for elevated irritability, items 22, 27, 51, and 54 (Cronbach’s α .71).
Sleep disturbance was assessed using the seven-item sleep subscale from the P-GBI,
(Cronbach’s α 0.83) (Meyers & Youngstrom, 2008).
Family Index of Risk for Mood—(Used to measure: Family History). Family psychiatric
health history was assessed using Family Index of Risk for Mood (FIRM) (Algorta et al.,
under review). The FIRM provides a simple method by which information about study
participants’ family history of mental health issues can be gathered. It consists of an array of
questions about mental health history for close relatives (parents, grandparents, aunts/uncles,
siblings and children), resulting in a total of 25 checkboxes that respondents can endorse;
higher scores indicate greater psychopathology among family members. The FIRM was
validated in a pediatric bipolar study of 162 families. The family history information showed
a clinically meaningful association with youth diagnoses of PBD and the number of family
risk factors discriminated cases with diagnoses of PBD from all other cases. Because this
measure was developed towards the end of the protocol, scores are only available on a
subset of cases.
Child’s Global Assessment Scale—(Used to measure: Level of Functioning). The C-
GAS (Shaffer et al., 1983)was used to gauge youth’s current level of overall functioning.
Participants’ C-GAS scores were used to control for degree of impairment, which may
account for greater variability in symptom severity than diagnosis.
Procedure
All caregivers signed written consent, and youth participants provided written assent. The
youth and parent each completed the K-SADS interview separately (administered by the
same interviewer). While the parent was being interviewed, youth 11 years and older
completed a series of questionnaires. While the child was being interviewed, the caregiver
completed the P-GBI, FIRM, and other questionnaires. The scores on all questionnaires
were recused from the consensus diagnosis meeting, which followed the Longitudinal
Evaluation of All Available Data (LEAD) procedure (Spitzer, 1983).
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Analytic Plan—Age, gender, substance use and C-GAS score were covariates in
subsequent analyses as covariates. Historically, bipolar disorder has been considered an
adult diagnosis, though it is now accepted that bipolar occurs in children, risk is thought to
increase through adolescence into early adulthood (Shankman et al., 2009). Although
previous research has not found sex differences in the prevalence of bipolar disorder
(Merikangas et al., 2007), it may be that there are differences in youth clinical diagnosis,
with boys more likely to receive a diagnosis of bipolar than girls (Moreno et al., 2007).
Substance use is often associated with other psychiatric disorders, including pediatric
bipolar disorder (Brook, Cohen, & Brook, 1998; Kandel et al., 1997; Wilens et al., 1999).
Chi-squared analyses compared rates and categorical variables across diagnostic groups.
Scores from the P-GBI and family risk factors were converted into a percent of the
maximum possible score (POMP). Converting summed scores into percents provides a
framework by which to interpret differences (Cohen, Cohen, Aiken, & West, 1999).
ANOVA was used to compare means on rating scales and family history. Linear regression
models were used to compare mean differences, while controlling for gender, age, and C-
GAS. Repeated-measures ANOVA was used to investigate the pattern of irritability across
elevated and depressive periods. Post-hoc comparisons used Tukey’s HSD procedure, which
allows for between-group comparisons following an ANOVA, correcting for the increased
likelihood of Type I error due to multiple comparisons.
Results
Preliminary analyses
The sample was comprised of 496 (60%) male participants and 331 (40%) female
participants. The sample had an average age of 10.92 years (SD=3.44). Sixty-nine percent
(N=573) of subjects reported their race as Black, 22% (N=185) White, 2% (N=20)
Hispanic, .2% (N=2) Asian, and 5% (N=45) reported race as Other. Two people declined to
report race information.
There was no gender difference in the rate of bipolar disorders (X2(1)=2.2, p=.13); nor was
there any difference in the average age of youths with versus without bipolar disorders
(F(1)=1.0, p=.31). Sixteen percent of the sample met criteria for any substance use, with no
difference between those participants on the bipolar spectrum and the rest of the sample
(X2(1)=2.6, p=.12). There was a significant difference in mean C-GAS score between
participants with bipolar spectrum disorders (49.1) and those with non-affective disorders
(53.1), (F(1)=52.6, p<.0001).
Irritability
The mean elevated irritability score for youth with cyclothymia was 33 (SD=21),
significantly higher than the mean score of 23 (SD=22) for the rest of the sample (all youth
without a diagnosis of cyclothymia) (t(808)=−3.21, p<.001). There were also significant
differences in total irritability scores across diagnostic groups, (p<.0001). The mean
depressive irritability score for youth with cyclothymia was 43 (SD=19), also significantly
higher than the mean score of 29 (SD=24) for the rest of the sample (t(808) =−4.11, p>.
0001). See Table 1.
Repeated-measures ANOVA, investigating the pattern of irritability across elevated and
depressive periods, was significant (F(3)=4.63, p<.01), such that the difference in level of
irritability across elevated and depressed episodes depended on the bipolar subtype. Further
consideration of the mean difference between elevated and depressive irritability across
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bipolar subtypes indicated that participants with BP II have a larger difference between
levels of irritability than each of the other BP subtypes (p<.05). See Figure 1.
The hypothesis that youth with cyclothymia will have similar levels of irritability in both
elevated and depressive episodes, was not supported; there was significantly greater
irritability experienced during depressive periods (t(51)= −3.59, p<.001).
Comorbidity
Of the 52 youth with cyclothymia in the sample, 51 (98%) met criteria for a comorbid
diagnosis. Nineteen (37%) had a comorbid anxiety disorder. This is not significantly
different from the rest of the sample (X2(1)=3.37, p =.07). Forty-three of the youth with
cyclothymia (83%) had comorbid ADHD; significantly more than the rest of the sample
(X2(1)=9.13, p<.005).
As a group, the bipolar subtypes do not differ in the number of total comorbid diagnoses
(F(3)=2.3, p=.08). See Table 2. However, youth with cyclothymia were the most likely to
meet ADHD criteria. Youth with cyclothymia did have a higher number of comorbid
diagnoses than those youth without bipolar spectrum disorders (F(4)=23.8, p<.0001).
Age of onset
Thirty-eight of the youth with cyclothymia (73%) had symptom onset prior to the age of 10.
This is significantly different from the rest of the sample, 32% of whom had onset before 10,
(X2(1)=14.76, p<.0001). However, youth with cyclothymia were not more likely to have
mood onset prior to age 10 than the other bipolar spectrum disorders, (X2(3)=6.04, p=.11).
Cox regression examined whether or not youth with cyclothymia exhibit mood
symptomatology at younger ages than children with other bipolar subtypes. Cyclothymia
had a younger age of onset than bipolar II, (Wald=5.6, p<.05). See Figure 2.
Forty-three of the youth with cyclothymia (83%) experienced depressive symptoms before
experiencing hypomanic symptoms. However, there was no difference in the polarity of the
index episode between bipolar subtypes (p=.91); all bipolar subtypes were more likely to
report depressive, rather than hypomanic, symptoms first.
Sleep disturbance
Youth with cyclothymia had a mean score of 31 (SD=21) on the P-GBI sleep subscale,
significantly higher than the rest of the study sample (mean=22, SD=22) (t(808)= −2.77, p<.
01).
Youth with cyclothymia scored significantly higher on the P-GBI sleep scale than youth
with non-bipolar spectrum disorders (p<.0001) with the exception of those youth with
depression (mean=26, SD=22) (p=0.4). When compared to other youth with bipolar
spectrum disorders, youth with cyclothymia differed only from those with BP II (p<.01), the
mean score for youth with cyclothymia (31) was lower than those with BP II (53).
Family history
All of the youth with cyclothymia in the sample for whom family history was reported had
family history of psychiatric disorder. See Table 3. Youth with cyclothymia had
significantly greater family history of psychiatric disorder than the rest of the sample (p <.
05). Additionally, youth with cyclothymia had greater family history of bipolar disorder than
the rest of the sample (p <.01).
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Youth with cyclothymia had more family risk for psychiatric disorder than those with
disruptive behavior disorders (p<.001), ADHD (p<.0001), and depression (p<.05).
Additionally, youth with cyclothymia had more family history of mood than disruptive
behavior disorders (p<.0001), ADHD (p<.0001), and depression (p<.05). Youth with
cyclothymia also had more family risk for bipolar disorder than disruptive behavior
disorders (p<.01) and ADHD (p<.001).
There was no difference in the level of familial bipolar risk between the bipolar subtypes.
Similarly, there was not a significant difference between bipolar subtypes in the level of
general psychiatric illness risk, though the scores vary (Cyclothymia mean=51, BP I
mean=13, BP II mean=32, BP NOS mean=32). Unfortunately, these analyses are
underpowered, due to small sample size with family history information available.
Discussion
The primary aim of this study was to examine the validity of cyclothymic disorder in a
youth population using the diagnostic validation system proposed by Robins and Guze
(1970). In this study of 827 youth seen for outpatient services, we were able to address three
of the five major categories of validation: The data related to Clinical Description,
Delimitation from Other Disorders, and Family Studies makes a compelling argument for
the inclusion of cyclothymia on the bipolar spectrum, and offers clues for future areas of
research.
Irritability
Youth with cyclothymia in the sample exhibited high levels of irritability associated with
both depressive and elevated mood; a diagnosis of cyclothymia was a significant predictor
of high total irritability (elevated or depressed) – more so than any of the other, non-BP
disorders. Whereas we hypothesized that, on average, cyclothymia would be associated with
similar levels of irritability across moods, depressive irritability was more severe. This is
clinically important, given the fact that people with cyclothymia are more likely to be seen
for treatment during depressive episodes (Akiskal et al., 1977). It may be that the heightened
irritability signals increased internal agitation, which is more unpleasant both for the
individual with cyclothymia and for those close to him/her. Interestingly, youth with
unipolar depression had similar levels of average irritability to youth with cyclothymia. This
suggests that the overall irritability score may be driven by the depressive irritability score.
Whereas irritability is most often discussed with regard to periods of elevated mood in
bipolar disorder (Biederman et al., 2000; Kowatch et al., 2005; Wozniak et al., 1995), it
appears that irritability during depressive episodes may, in fact, be more severe.
Comorbidity
Cyclothymic disorder was almost always comorbid with at least one other condition. The
rate of comorbid ADHD among the youth with cyclothymia (83%) was, if anything, higher
than anticipated. Previous studies have found rates closer to 60% among both youth with
cyclothymia and the other bipolar subtypes (Birmaher et al., 2006; Findling et al., 2005),
though rates as high as 97% have been reported for BP I (Biederman et al., 2005). More
interesting is the fact that the youth with cyclothymia had higher rates of ADHD than the
other bipolar subtypes. This may provide some support to the theory that cyclothymia is
associated with more varied family history of psychiatric disorder, beyond just mood
disorder, and that those with cyclothymia are more likely to also suffer from other disorders.
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The mean age of mood symptom onset for youth with cyclothymic disorder was six years,
five months. This supports a growing body of evidence that bipolar disorder very often does
begin in childhood (Lewinsohn et al., 2000; Perlis et al., 2004). And, while the differences in
age of onset between bipolar subtypes failed to reach significance, the average age of onset
for youth with cyclothymia was a full year younger than that for BP I and NOS and two and
a half years younger than onset for BP II. An earlier age of onset associated with
cyclothymia could support the theory that cyclothymia has a more trait-like, temperamental
foundation and chronic course (Akiskal, 1996; Akiskal & Akiskal, 1992; Geller, Tillman,
Bolhofner, & Zimerman, 2008; McElroy et al., 1997; Perlis et al., 2004). Given the
relatively small number of participants from which to make these comparisons, additional,
prospective research is indicated to further explore this potential difference.
The hypothesis that youth with cyclothymia would tend to have a depressive episode before
exhibiting hypomanic symptoms was supported, although they were not any more likely
than the other bipolar subtypes to exhibit this pattern. Previous research has repeatedly
found that depressive episodes tend to precede [hypo]manic episodes in bipolar youth
(Birmaher et al., 2009; Strober et al., 1995). Unfortunately, these data tend to be
retrospective, as is the case with the current study; therefore, the report of symptom onset
may be confounded with the increased likelihood that people with cyclothymia will seek
treatment during depressive episodes (Akiskal et al., 1977; Youngstrom, 2009).
Sleep disturbance
As expected, youth with cyclothymia reported disrupted sleep. Though the mean score on
the P-GBI sleep subscale was lower than the mean score found previously for bipolar youth
(Meyers & Youngstrom, 2008), it was significantly higher than the sleep disturbance
reported by those youth without bipolar disorder in this sample. There is evidence to support
the theory that bipolar disorders are caused, in part, by abnormalities of an individual’s
circadian rhythms that can “trigger” affective episodes (Grandin, Alloy, & Abramson, 2006;
Harvey et al., 2006). The fact that the youth with cyclothymia in this study shared symptoms
of sleep disruption with the other bipolar subtypes – but not with those unaffected by bipolar
disorders – is important: Based on the circadian rhythm theory, it suggests a shared biology
among the bipolar disorders.
Family history
Youth with cyclothymia had greater family history of psychiatric disorder than the non-
bipolar youth. Additionally, they had greater family history of mood disorder than those
youth with disruptive behavior disorders, ADHD, and depression. Interestingly, the youth
with depression and youth with cyclothymia had similar rates of familial bipolar disorder.
This supports the theory that heritability of mental illness is not always specific; but it also
suggests that these are all on a spectrum of mood disorder (DelBello & Geller, 2001).
Youth with cyclothymia did not differ from other bipolar subtypes in their reported family
history of psychiatric disorder (mood or other). These results offer further evidence that
cyclothymia is on the mood disorder spectrum, and is associated with heritable risk.
Conclusion
The present study explored both similarities and differences across the bipolar spectrum, the
results indicate that cyclothymia is, in fact, on the bipolar spectrum (and would not be better
cast as a temperament or personality disorder), but retains characteristics that distinguish it
from the other subtypes. Distinguishing cyclothymia from BP NOS is, as hypothesized,
challenging and perhaps not possible based solely on levels of irritability, comorbid
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diagnoses, or family history, alone. That is not to say that cyclothymia is distinguishable
only by DSM criteria, which are admittedly imperfect; many of the results seem to hint at
differences that may have failed to reach significance simply because the sample was not
large enough. Based on the findings in this study, further investigation of comorbid ADHD,
family history and age of onset, in particular, is indicated.
Limitations and future directions—The current study was proposed and executed as an
exploration of the diagnosis of cyclothymic disorder in young people. Given the lack of
previous research on this population, this study contributed important information about the
phenomenology, etiology and comorbid conditions associated with this disorder. Still, there
are limitations worth noting. Because it is theorized that cyclothymia may result from a
varied genetic foundation, resulting in more pervasive, undifferentiated impairment, the
results of genetic and biologic studies are of particular interest, but were not addressed in
this study. Greater understanding of the systems implicated in the origin and maintenance of
cyclothymia could provide valuable clues into the origin and course of this chronic,
debilitating disorder.
The present study is unable to comment on characteristics of the course of cyclothymia,
including episode pattern / duration and prognosis. Given that its chronic nature is one if the
primary features of the disorder, this is a significant limitation. Unfortunately, cyclothymia
has not been differentiated in any of the pediatric longitudinal studies reported to-date –
even though the outcome for cyclothymic youth should be of great interest. Specifically,
given that cyclothymia may be the most prevalent form of bipolar in adults – and that BP
NOS is (by clinical diagnosis) more prevalent in children than adults, following the course
of these two subthreshold forms of bipolar disorder may help to elucidate differences. Most
importantly, what is the course of chronic, early-onset bipolar spectrum disorder? Who
among the subthreshold cases goes on to develop BP I or II, whose symptoms remit? Data
from a large, longitudinal study suggests that subsyndromal cases of pediatric bipolar
disorder are likely to convert to BP I or II (Birmaher et al., 2009; Birmaher et al., 2006).
However, this study does not distinguish between BP NOS and cyclothymic disorder, so it is
impossible to draw conclusions about why 38% of cases progressed over the four-year
follow-up and the rest did not. Additionally, there is evidence to suggest that some forms of
pediatric bipolar disorder may resolve in young adulthood, without future episodes (Cicero,
Epler, & Sher, 2009). Without prospective tracking of the specific characteristics of
subthreshold bipolar subtypes, along with risk and protective factors, the gains possible from
the field of bipolar research are limited. Subthreshold subtypes likely represent the greatest
opportunity for preventative measures (Miklowitz & Chang, 2008).
In conclusion, the results of this study suggest that cyclothymia is firmly situated on the
mood disorder spectrum. It shares characteristics with both other bipolar disorders and
depression. The discussion regarding whether or not depression and bipolar disorder are on
the same spectrum is ongoing (Angst et al., 2010; Goodwin & Jamison, 2007), but it seems
that further investigation of cyclothymia may offer some answers, not only about the mood
spectrum, but about its interactions with temperament, circadian rhythms and other
disorders.
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Difference in irritability between depressive and elevated periods
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Survival analysis of age of mood symptom onset by bipolar subtype
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DBD 139 3.2(1.4)* 9§ 58§
ADHD 197 3.3(1.2)* 12§ -
Depression 222 4.1(1.8)* 33 48§
Cyclothymia 52 4.9(1.6) 37 83
BP NOS 52 4.2(1.6) 28 57
BP II 18 4.2(2.2) 50 50
BP I 31 4.0(1.6) 35 61
*
Significantly different (p<.05)from cyclothymia based on Tukey’s HSD posthoc test
§
Significantly different (p<.05)from cyclothymia based on Kruskal-Wallis nonparametric test
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Table 3
Percent with family risk factors for psychiatric disorder by diagnosis






DBD 42 71 52 31
ADHD 69 70 48 23
Depression 86 80 71 46
Cyclothymia 15 100 93 60
BP NOS 19 84 79 42
BP I &II 9 83 50 33
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